Safety and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Advanced Breast Cancer: A Head-to-Head Comparison of Margetuximab versus Trastuzumab
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-01-01
|
| Series: | Asia-Pacific Journal of Oncology Nursing |
| Online Access: | http://www.apjon.org/article.asp?issn=2347-5625;year=2021;volume=8;issue=4;spage=349;epage=351;aulast=Zhang |
| _version_ | 1797763570737348608 |
|---|---|
| author | Liyi Zhang |
| author_facet | Liyi Zhang |
| author_sort | Liyi Zhang |
| collection | DOAJ |
| first_indexed | 2024-03-12T19:44:24Z |
| format | Article |
| id | doaj.art-881355040bac4a34bebc5f68303c492e |
| institution | Directory Open Access Journal |
| issn | 2347-5625 2349-6673 |
| language | English |
| last_indexed | 2024-03-12T19:44:24Z |
| publishDate | 2021-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Asia-Pacific Journal of Oncology Nursing |
| spelling | doaj.art-881355040bac4a34bebc5f68303c492e2023-08-02T03:39:47ZengElsevierAsia-Pacific Journal of Oncology Nursing2347-56252349-66732021-01-018434935110.4103/apjon.apjon-2128Safety and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Advanced Breast Cancer: A Head-to-Head Comparison of Margetuximab versus TrastuzumabLiyi Zhanghttp://www.apjon.org/article.asp?issn=2347-5625;year=2021;volume=8;issue=4;spage=349;epage=351;aulast=Zhang |
| spellingShingle | Liyi Zhang Safety and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Advanced Breast Cancer: A Head-to-Head Comparison of Margetuximab versus Trastuzumab Asia-Pacific Journal of Oncology Nursing |
| title | Safety and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Advanced Breast Cancer: A Head-to-Head Comparison of Margetuximab versus Trastuzumab |
| title_full | Safety and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Advanced Breast Cancer: A Head-to-Head Comparison of Margetuximab versus Trastuzumab |
| title_fullStr | Safety and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Advanced Breast Cancer: A Head-to-Head Comparison of Margetuximab versus Trastuzumab |
| title_full_unstemmed | Safety and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Advanced Breast Cancer: A Head-to-Head Comparison of Margetuximab versus Trastuzumab |
| title_short | Safety and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Advanced Breast Cancer: A Head-to-Head Comparison of Margetuximab versus Trastuzumab |
| title_sort | safety and efficacy of human epidermal growth factor receptor 2 targeted therapies in advanced breast cancer a head to head comparison of margetuximab versus trastuzumab |
| url | http://www.apjon.org/article.asp?issn=2347-5625;year=2021;volume=8;issue=4;spage=349;epage=351;aulast=Zhang |
| work_keys_str_mv | AT liyizhang safetyandefficacyofhumanepidermalgrowthfactorreceptor2targetedtherapiesinadvancedbreastcanceraheadtoheadcomparisonofmargetuximabversustrastuzumab |